Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The epidermal barrier, primarily located within the stratum corneum, is a specialized structure composed of protein-rich corneocytes embedded in a lipid-rich extracellular matrix [1]. This "bricks and mortar" arrangement consists of proteins such as keratin, filaggrin, and loricrin, alongside lipids including ceramides, cholesterol, and free fatty acids [2][3]. Its primary biological function is to maintain homeostasis by preventing transepidermal water loss (TEWL) and acting as a physical and chemical shield against environmental pathogens and allergens [1]. In conditions like atopic dermatitis, psoriasis, and xerosis, the barrier is often compromised due to genetic deficiencies or environmental damage, leading to inflammation and infection [2]. Therapeutic strategies target these structures using emollients to provide occlusion, humectants to draw in moisture, and barrier-repair creams that replenish missing lipid components [4].
Occlusion of the stratum corneum to prevent water loss, humectancy to attract moisture, and replenishment of essential lipids to restore structural integrity [1][4].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal barrier components.